BACKGROUND: Intravenous ergonovine and intracoronary acetylcholine tests have been used to induce coronary artery spasm, however, potential preblems with each test require a safer and more specific test. METHODS: To evaluate the usefulness of the intracoronary ergonovine provocation test in patients with coronary artery spasm, this test was performed in 83 patients(male 47, female 36) with normal or near-normal looking coronary angiography or insignificant lesion less than 50% in diameter after routine diagnostic coronary angiography. Ten micrograms of ergonovine maleate diluted in 1 ml of saline was injected into right coronary artery up to 2 times and into left coronary artery up to 3 times. Induction of coronary arterial narrowing more than 75% of luminal diameter with typical chest pain and/or ECG changes in two or more adjacent leads was considered as a positive test. RESULTS: Intracoronary ergonovine provocation tests were positive in 33 patients among 83 patients. In 24 patients, coronary artery spasm was induced in RCA, 12 patients in LAD and 8 patients in LCX. Coronary artery spasm of 2 sites was observed in 11 patients. In 27 patients, typical chest pain was developed with spasm. The ECG changes during spasm were ST elevation in 19 patients, ST depression in 3 patients, T wave change only in 2 patients and no change in 9 patients. The provocation tests showed focal spasm in 23 patients(70%) and diffuse spasm in 10 patients(30%). CONCLUSION: Intracoronary ergonovine provocation test appears to be a safe and effective method to provoke the coronary artery spasm.
Acetylcholine ; Chest Pain ; Coronary Angiography ; Coronary Vessels* ; Depression ; Electrocardiography ; Ergonovine* ; Female ; Humans ; Phenobarbital ; Spasm*

The ventriculoatrial(VA) intervals during supraventricular tachycardia(VAsvt) and during pacing with same cycle length as tachycardia(VApace) were analysed in 48 patients to evaluate the usefullness in determining the mechanism of paroxysmal supraventricular tachycardia(PSVT) and the sites of accessory pathways. The results are as follows : 1)In differenciation AV nodal reentry from AV reentry mechanism, VAsvt(25.6+/-21.5 vs 148.0+/-27.7msec, p<0.01), VApace-VAsvt(135.3+/-15.7 vs 55.0+/-33.5msec,p<0.01), and VAsvt/VApace(0.15+/-0.10 vs 0.75+/-0.14,p<0.05) were useful. Cutoff values were 95msec in VAsvt, 110msec in VApace-VAsvt and 0.5 in VAsvt/VApace. 2) There were no overlaps in VA intervals between the AV nodal reentry group and the AV reentry group with posteroseptal accessory pathway.3) In AV reentry tachycardia, VApace-VAsvt>50msec(sensitivity 81%,specificity 100%) and VAsvt/VAace<0.7(sensitivity 71%, specificity 100%) suggested the high probability of left free wall accessory pathway. In Conclusion, VAsvt, VApace-VAsvt and VAsvt/VApace are useful parameters in determining the mechanism of PSVT and the sites of accessory pathways.
Humans ; Sensitivity and Specificity ; Tachycardia

We present a case of giant coronary arteriovenous fistula between left main coronary artery and pulmonary artery in a 60-year-old female who presented with anginal symptom. Dobutamine stress echocardiography and myocardial perfusion scan with (99m)Tc-MIBI revealed a reversible perfusion defect in the septal region. Coronary angiography demonstrated a giant coronary arteriovenous fistula origination from the left main coronary artery and draining into the pulmonary artery. This appears to be the first case in which dobutamine stress echocardiography and myocardial perfusion scan with (99m)Tc-MIBI demonstrated myocardial ischemia due to coronary steal in patient with a coronary arteriovenous fistula.
Arteriovenous Fistula* ; Coronary Angiography ; Coronary Vessels ; Dobutamine* ; Echocardiography, Stress* ; Female ; Humans ; Middle Aged ; Myocardial Ischemia ; Perfusion ; Pulmonary Artery ; Septum of Brain ; Tomography, Emission-Computed, Single-Photon*

OBJECTIVE: This is designing the part of Electronic Medical Record using HL7 Development Framework and Reference Information Model to realize the building medical standard data model for sharing medical record between heterogeneous hospital systems. METHODS: The process used development of HL7 specifications consists of the following seven activities: 1.Project initiation. 2.Requirements Documentation. 3.Specification Modeling. 4.Specification Documentation. 5.Specification Approval. 6. Specification Publication. 7.Implementation Profiling. Each activity is briefly described in the subsections that follow and described in detailed in the methodology chapters that follow this introduction.3. Result. The steps, after 4 step, needs to standardized the results. So we didn't followed that steps1). RESULTS: We got the diagrams at each steps of the HDF methodology: 1.A dynamic description. 2.A static description of the concepts involved in the business process. 3.A Use Case model which identifies the system involved in the actual HL7 data/information exchange1). CONCLUSION: It was confirmed that HL7 RIM could take in the domestic demands of medical records, and concrete methodology was applied in practice. It can be a good reference for the hospitals constructing new information system and for the enterprises developing medical information systems to apply the HL7 version 3 to their works.
Commerce ; Electronic Health Records* ; Health Level Seven* ; Health Status* ; Information Systems ; Medical Records ; Publications

BACKGROUND: Pulmonary venous flow(PVF) is closely related to left atrial pressure(LAP) and percutaneous mitral commissurotomy(PMC) reduces LAP rapidly. However, PVF pattern in mitral stenosis(MS) with sinus rhythm after PMC remains to be elucidated. METHODS: Transesophageal echocardiographic pulsed Doppler examination was performed within 24 hours before and after PMC to evaluate PVF pattern in 10 patients of MS with sinus rhythm. RESULTS: Before PMC, both peak velocity(PV) and velocity time integral(VTI) during systole had significant negative correlations with mean LAP(r=-0.70, r=-0.79, respectively). After PMC, both systolic PV and VTI increased significantly without significant changes in diastolic PV and VTI. However, there was no significant correlation between systolic PV and mean LAP, and between systolic VTI and mean LAP after PMC. CONCLUSION: In mitral stenosis with sinus rhythm, these data suggest that systolic PVF decreases with increase of mean LAP and PMC could reverse this change without affecting diastolic PVF. However, acute hemodynamic changes of left atrium induced by PMC may contribute to the absence of correlation between mean LAP and systolic PVF after PMC.
Echocardiography* ; Heart Atria ; Hemodynamics ; Humans ; Mitral Valve Stenosis ; Systole

Urological complications are not uncommon in Crohn's disease (CD). The most common manifestations are renal stones, enterovesical fistulas, and ureteral obstruction, but renal parenchymal disease has rarely been reported. IgA nephropathy, the most common form of primary glomerulonephritis, is usually isolated, but can be sometimes associated with chronic extrarenal disorders such as inflammatory bowel disease. We describe a case of 36 year-old man with CD associated with IgA nephropathy. He was diagnosed as CD 6 years ago and at that time, isolated proteinuria was observed. He presented recurrent proteinuria and elevation of creatinine level while he had been managed well with mesalamine and azathioprine. The renal biopsy was performed and IgA nephropathy (type IV) was diagnosed. Strict blood pressure control with angiotensin converting enzyme inhibitor and calcium channel blocker resulted in clinical improvement and normalization of serum creatinine level.
Adult ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Antimetabolites/therapeutic use ; Azathioprine/therapeutic use ; Blood Pressure ; Calcium Channel Blockers/therapeutic use ; Colonoscopy ; Crohn Disease/*diagnosis/drug therapy/etiology ; Glomerulonephritis, IGA/complications/*diagnosis/pathology ; Humans ; Male ; Mesalamine/therapeutic use ; Proteinuria/diagnosis/etiology

BACKGROUND: Atrioventricular reentry is the most common cause of supraventricular tachycardia in Korea. Radiofrequency catheter ablation(RFCA) is now accepted to be the safe and effective treatment modality for the elimination ofr accessory pathway conduction in patient with atrioventricualr reentrant tachycardia(AVRT). METHODS: To evaluate the clinical usefulness of RFCA for the treatment of AVRT, this study was conducted in 109 patients(male 68, female 41) with atrioventricular accessory pathway and documented AVRT after electrophysiologic study. RESULTS: A total of 112 accessory pathways were identified in 109 patients. The mean power outputs of the successful ablations at the atrial side of the annulus were higher than those at the ventricular side(34.0+/-8.9W versus 20.0+/-7.6W, p<0.01), but the maximum temperatures were lower at the atrial side of the annulus than those at the ventricular side (66.4+/-14.0degrees C versus 77.2+/-6.4degrees C, p<0.01). Accessory pathway conduction was eliminated in 102 of 112 pathways successfully(success rate 91v). There were 4 nonfatal complications(3.7%). 3 patients with hemopericardium and 1 with femoral artery thrombus, during or after ablation porcedures. Recurrences of AV reentrant tachycardia or delta wave on the electrocardiogram occured in 5 patients, and 4 of them had successful second procedures. There were no late complications during a mean follow-up period of 13+/-5 months. CONCLUSION: RFCA is highly effective and safe treatment modality in ablation accessory pathway conduction.
Catheter Ablation* ; Catheters ; Electrocardiography ; Female ; Femoral Artery ; Follow-Up Studies ; Humans ; Korea ; Pericardial Effusion ; Recurrence ; Tachycardia* ; Tachycardia, Supraventricular ; Thrombosis

BACKGROUND: Myocardial contractile dysfunction is often noticed without myocardial infarction, it may be due to myocardial stunning or hibernation. There are several case reports of myocardial stunning in patients with variant angina, but effect of recurrent myocardial spasm on myocardial contratile function in human is not well established. METHODS: To evaluate the effect of recurrent spasm-induced myocardial ischemia on myocardial contractile function, we analyzed the ejection fraction(by area-length method) and regional wall motion(by centerline method) at before and after intracoronary nitroglycerin in variant angina group and control group. Variant angina group consisted of 15 patients(LAD ; 10 patients, RCA ; 5 patients) and normal control group consisted of 6 patients. RESULTS: Ejection fraction increment after nitroglycerin infusion was not significant in normal control group, but that in variant angina group was significant(p<0.05). Pre-NG shortening fraction of LAD territory on both RAO and LAO view in patients with spasm in LAD was significantly lower than that in patients without spasm in LAD(RAO ; p<0.05, LAO ; p<0.01). On LAO view pre-NG shortening fraction of LAD territory in 6 patients with spasm and without significant fixed lesion was lower than that in patients without spasm in LAD(p<0.05). Shortening fraction increment after nitroglycerin infusion in LAD territory on both RAO and LAO view was significant in patients with spasm in LAD(RAO ; 0.05, LAO ; p<0.01), but that in LCX or RCA territory and that in LAD territory of patients without spasm in LAD was not significant. Shortening fraction increment after nitroglycerin infusion in RCA territory on LAO view was significant in patients with spasm in RCA(p<0.05), but that in LAD or LCX territory and that RCA territory of patients without spasm in RCA and was not significant. CONCLUSION: These observations suggest that recurrent coronary artery spasm results in reversible dysfunction of the ventricular global and regional contractility, and myocardial stunning may be the cause of this phenmenon.
Coronary Vessels* ; Hibernation ; Humans ; Myocardial Infarction ; Myocardial Ischemia ; Myocardial Stunning ; Nitroglycerin ; Spasm*